国产亚洲成AV人片在线观黄桃,国产无遮挡裸体免费视频在线观看,露小内裤奶头白丝JK水手维特,AA片在线观看视频在线播放

首頁(yè) > 產(chǎn)品目錄 > 信號(hào)通路 > Protein Tyrosine Kinase/RTK > c-Fms > Sotuletinib (BLZ945)

Sotuletinib (BLZ945)

ChemLeader 98+%

Sotuletinib (BLZ945)

產(chǎn)品編號(hào):CL2550 CAS No.:953769-46-5 MDLNo: 分子式:C20H22N4O3S 分子量:398.48
規(guī)格 庫(kù)存 目錄價(jià) 會(huì)員專(zhuān)享價(jià) 數(shù)量
5 mg 3-5days ¥600.00 登錄后可見(jiàn)
- +
10 mg 3-5days ¥900.00 登錄后可見(jiàn)
- +
25 mg 3-5days ¥1600.00 登錄后可見(jiàn)
- +

化學(xué)品安全說(shuō)明書(shū)(MSDS)

下載MSDS
  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻(xiàn)
基本信息
英文名稱(chēng) Sotuletinib (BLZ945)
中文名稱(chēng)Sotuletinib (BLZ945)
CAS號(hào)953769-46-5
分子式C20H22N4O3S
分子量398.48
外觀Off-white to light brown powder
儲(chǔ)存條件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產(chǎn)品詳情

Sotuletinib (formerly BLZ945; BLZ-945) is a novel, potent, selective, orally bioactive, and brain-penetrant CSF-1R (colony stimulating factor 1 receptor) inhibitor with potential antitumor activity. It exhibits 1000-fold higher selectivity against its closest receptor tyrosine kinase homologs and inhibits CSF-1R with an IC50 of 1 nM. Glioma-bearing mice demonstrate high in vivo antitumor efficaciousness of BLZ945. Sotuletinib was designated as an orphan drug by the US FDA in August 2022 in order to treat patients suffering from Amyotrophic Lateral Sclerosis (ALS), a progressive neurological disorder that affects nerve cells in the brain and spinal cord and results in loss of motor control.

相關(guān)文獻(xiàn)
抱歉,暫時(shí)沒(méi)有相關(guān)文獻(xiàn)
相關(guān)產(chǎn)品
抱歉,暫時(shí)沒(méi)有相關(guān)產(chǎn)品
在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時(shí)間: 工作日 9:00-18:00
闽清县| 平山县| 杂多县| 东至县| 晋宁县| 嵩明县| 仁化县| 郯城县| 全椒县| 永年县| 丰原市| 南华县| 赤壁市| 海兴县| 镇远县| 丰城市| 开鲁县| 汉川市| 通渭县| 柳河县| 剑河县| 隆化县| 武宣县| 会宁县| 清苑县| 安吉县| 萍乡市| 呈贡县| 清新县| 通海县| 大方县| 垫江县| 资中县| 青州市| 谷城县| 龙井市| 仲巴县| 内乡县| 康平县| 湛江市| 西城区|